GB9210574D0 - Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications - Google Patents

Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications

Info

Publication number
GB9210574D0
GB9210574D0 GB929210574A GB9210574A GB9210574D0 GB 9210574 D0 GB9210574 D0 GB 9210574D0 GB 929210574 A GB929210574 A GB 929210574A GB 9210574 A GB9210574 A GB 9210574A GB 9210574 D0 GB9210574 D0 GB 9210574D0
Authority
GB
United Kingdom
Prior art keywords
pct
skin
cell
biotherapeutic
burn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929210574A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Original Assignee
National Research Council of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council of Canada filed Critical National Research Council of Canada
Priority to GB929210574A priority Critical patent/GB9210574D0/en
Publication of GB9210574D0 publication Critical patent/GB9210574D0/en
Priority to AU42579/93A priority patent/AU668959C/en
Priority to PCT/CA1993/000187 priority patent/WO1993023088A1/en
Priority to DK93911706T priority patent/DK0641223T3/da
Priority to EP93911706A priority patent/EP0641223B1/en
Priority to RU94046192A priority patent/RU2104039C1/ru
Priority to KR1019940704108A priority patent/KR950701533A/ko
Priority to AT93911706T priority patent/ATE203916T1/de
Priority to PT93911706T priority patent/PT641223E/pt
Priority to CA002135999A priority patent/CA2135999C/en
Priority to US08/338,596 priority patent/US5830507A/en
Priority to NZ252661A priority patent/NZ252661A/en
Priority to DE69330562T priority patent/DE69330562T2/de
Priority to ES93911706T priority patent/ES2161229T3/es
Priority to JP5519724A priority patent/JP2820796B2/ja
Priority to BR9306375A priority patent/BR9306375A/pt
Priority to GR20010401598T priority patent/GR3036741T3/el
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/985—Skin or skin outgrowth, e.g. hair, nails
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2531/00—Microcarriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB929210574A 1992-05-18 1992-05-18 Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications Pending GB9210574D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB929210574A GB9210574D0 (en) 1992-05-18 1992-05-18 Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
BR9306375A BR9306375A (pt) 1992-05-18 1993-04-23 Reposiçao de pele viva e processos para a produçao da mesma e de uso de microesferas revestidas de células
PT93911706T PT641223E (pt) 1992-05-18 1993-04-23 Microsferas revestidas com celulas bioterapeuticas
US08/338,596 US5830507A (en) 1992-05-18 1993-04-23 Biotherapeutic cell-coated microspheres
DK93911706T DK0641223T3 (da) 1992-05-18 1993-04-23 Bioterapeutiske celleovertrukne mikrosfærer
EP93911706A EP0641223B1 (en) 1992-05-18 1993-04-23 Biotherapeutic cell-coated microspheres
RU94046192A RU2104039C1 (ru) 1992-05-18 1993-04-23 Заменитель живой кожи, способ его получения и способ обработки повреждений живой кожи
KR1019940704108A KR950701533A (ko) 1992-05-18 1993-04-23 생체 치료학적 세포-피복된 중심체(Biotherapeutic cell-coated microspheres)
AT93911706T ATE203916T1 (de) 1992-05-18 1993-04-23 Biotherapeutische mikrosphären beschichtet mit zellen
AU42579/93A AU668959C (en) 1992-05-18 1993-04-23 Biotherapeutic cell-coated microspheres
CA002135999A CA2135999C (en) 1992-05-18 1993-04-23 Biotherapeutic cell-coated microspheres
PCT/CA1993/000187 WO1993023088A1 (en) 1992-05-18 1993-04-23 Biotherapeutic cell-coated microspheres
NZ252661A NZ252661A (en) 1992-05-18 1993-04-23 Living skin replacement comprising microspheres
DE69330562T DE69330562T2 (de) 1992-05-18 1993-04-23 Biotherapeutische mikrosphären beschichtet mit zellen
ES93911706T ES2161229T3 (es) 1992-05-18 1993-04-23 Microesferas bioterapeuticas revestidas con celulas.
JP5519724A JP2820796B2 (ja) 1992-05-18 1993-04-23 生物療法性細胞被覆微小球状体
GR20010401598T GR3036741T3 (en) 1992-05-18 2001-09-27 Biotherapeutic cell-coated microspheres.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929210574A GB9210574D0 (en) 1992-05-18 1992-05-18 Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications

Publications (1)

Publication Number Publication Date
GB9210574D0 true GB9210574D0 (en) 1992-07-01

Family

ID=10715656

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929210574A Pending GB9210574D0 (en) 1992-05-18 1992-05-18 Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications

Country Status (16)

Country Link
US (1) US5830507A (enExample)
EP (1) EP0641223B1 (enExample)
JP (1) JP2820796B2 (enExample)
KR (1) KR950701533A (enExample)
AT (1) ATE203916T1 (enExample)
BR (1) BR9306375A (enExample)
CA (1) CA2135999C (enExample)
DE (1) DE69330562T2 (enExample)
DK (1) DK0641223T3 (enExample)
ES (1) ES2161229T3 (enExample)
GB (1) GB9210574D0 (enExample)
GR (1) GR3036741T3 (enExample)
NZ (1) NZ252661A (enExample)
PT (1) PT641223E (enExample)
RU (1) RU2104039C1 (enExample)
WO (1) WO1993023088A1 (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654267A (en) * 1988-12-20 1997-08-05 La Jolla Cancer Research Center Cooperative combinations of ligands contained within a matrix
IL115728A0 (en) * 1994-10-25 1996-01-19 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US20020037566A1 (en) * 1997-04-16 2002-03-28 Rees Riley S. Cell-coated supports
US5972332A (en) 1997-04-16 1999-10-26 The Regents Of The University Of Michigan Wound treatment with keratinocytes on a solid support enclosed in a porous material
US5861149A (en) * 1997-06-04 1999-01-19 Polyheal Ltd. Methods for wound treatment
AU1664299A (en) * 1997-10-25 1999-05-17 Roche Diagnostics Gmbh Autodegradable microcarriers and their use
DE69819563T2 (de) * 1998-03-07 2004-09-16 Daewoong Pharmaceutical Co., Ltd., Sungnam Topische zusammensetzung enthaltend menschlichen epidermalen wachstumsfaktor
US6378527B1 (en) * 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
EP1071445A2 (en) * 1998-04-17 2001-01-31 Angiogenix, Incorporated Therapeutic angiogenic factors and methods for their use
ATE274050T1 (de) * 1998-04-17 2004-09-15 Nestle Sa Aus normalem menschlichem hautgewebe immortalizierte zellinien
KR100683603B1 (ko) * 1998-10-23 2007-02-20 폴리힐 엘티디. 창상 치유용 미소구 조성물
RU2195889C2 (ru) * 1999-05-24 2003-01-10 Парамонов Борис Алексеевич Способ дермабразии
DE19937102A1 (de) * 1999-08-06 2001-02-15 Universitaetsklinikum Freiburg Gewebeersatz und Verfahren zu seiner Herstellung
US7056503B2 (en) * 1999-08-19 2006-06-06 Regents Of The University Of Michigan Enclosures housing cell-coated supports for treating tumors
DE19949290A1 (de) * 1999-10-12 2001-04-26 Albrecht Bettermann Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin
RU2184491C2 (ru) * 2000-03-10 2002-07-10 Озерская Ольга Сергеевна Способ устранения косметических дефектов кожного покрова
KR20010110945A (ko) 2000-06-09 2001-12-15 김정용 음경 확대 방법
RU2184492C2 (ru) * 2000-06-13 2002-07-10 Озерская Ольга Сергеевна Способ дерматохирургического лечения гипотрофических рубцов
US6719970B1 (en) 2000-07-10 2004-04-13 Alkermes Controlled Therapeutics, Inc. Method of generating cartilage
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20030148924A1 (en) * 2002-07-09 2003-08-07 Tamar Tennenbaum Methods and pharmaceutical compositions of healing wounds
JP2002281964A (ja) * 2000-12-26 2002-10-02 Sanyo Chem Ind Ltd 細胞生産方法
AUPR289601A0 (en) * 2001-02-05 2001-03-01 Commonwealth Scientific And Industrial Research Organisation Method of tissue repair
RU2223790C2 (ru) * 2001-10-25 2004-02-20 ГФУН "Российский научно-исследовательский институт травматологии и ортопедии им. Р.Р. Вредена" Способ стерилизации биологических трансплантатов окисью этилена в жидкой среде
US20050129776A1 (en) * 2002-05-03 2005-06-16 Inserm Microparticles supporting cells and active substances
FR2839260B1 (fr) * 2002-05-03 2005-02-25 Inst Nat Sante Rech Med Microparticules a base d'un materiau bicompatible et biodegradable, supportant des cellules et des substances biologiquement actives
US7402323B2 (en) * 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
RU2210389C1 (ru) * 2002-09-10 2003-08-20 Общество с ограниченной ответственностью "Мединтер Плюс" Спасательное покрывало
EP1635782A1 (de) * 2003-05-24 2006-03-22 JUVENA (International) AG Gewebekulturmedien als bestandteil von kosmetika
ES2291890T3 (es) * 2003-06-23 2008-03-01 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Procedimiento para la diferenciacion de celulas madre en celulas que producen una hormona pancreatica.
JP4790609B2 (ja) * 2003-07-15 2011-10-12 バーイラン ユニバーシティー 創傷治癒のための方法及び薬剤組成物
ATE529125T1 (de) * 2003-08-07 2011-11-15 Healor Ltd Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
RU2240809C1 (ru) * 2003-08-26 2004-11-27 Государственное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии" Способ получения бесклеточного дермального матрикса
US20070020754A1 (en) * 2003-10-20 2007-01-25 Rui Yuge Cell handling device, human tissue regeneration composition, and human tissue regeneration method
EP2452691A3 (en) 2005-08-29 2012-09-05 HealOr Ltd. Methods and compositions for prevention of diabetic and aged skin
RU2316290C2 (ru) * 2005-11-21 2008-02-10 Институт биохимии им. А.Н. Баха РАН Сетчатый эндопротез для восстановительной хирургии
WO2008073614A2 (en) * 2006-11-02 2008-06-19 Akpharma Inc. Composition and method for enhancing skin cell growth, proliferation and repair
KR100805208B1 (ko) 2007-03-27 2008-02-21 주식회사 펩트론 엑센딘 함유 서방성 제제 조성물, 엑센딘 함유 서방성미립구 및 이의 제조 방법
WO2008154141A2 (en) * 2007-05-22 2008-12-18 Prelief Inc. Compositions and methods for preventing, minimizing and healing skin irritation and trauma
KR20130121678A (ko) * 2007-07-30 2013-11-06 힐로 리미티드 약제학적 조성물 및 관련 방법
US20100278798A1 (en) * 2007-09-27 2010-11-04 The Trustees Of Columbia University In The City Of New York Methods and systems for forming biocompatible materials
US8613776B2 (en) * 2007-12-27 2013-12-24 The Trustees Of Columbia University In The City Of New York Systems and methods for forming patterned extracellular matrix materials
PL2288376T3 (pl) 2008-04-18 2016-07-29 Collplant Ltd Sposoby generowania i wykorzystywania prokolagenu
CN102066904B (zh) 2008-06-13 2015-07-15 株式会社资生堂 皮肤代替膜、模具以及皮肤外用剂的评价方法
EA014044B1 (ru) * 2008-07-09 2010-08-30 Общество С Ограниченной Ответственностью "Аква-Альянс" Наносомальная лекарственная форма препарата пролонгированного действия для лечения гепатита с (варианты)
CN102740862B (zh) * 2009-12-04 2014-12-24 美格乐控股公司 具有内源性带电配体的水解淀粉微球
AU2011204425A1 (en) 2010-01-11 2012-08-02 Healor Ltd. Method for treatment of inflammatory disease and disorder
JP5241764B2 (ja) * 2010-03-31 2013-07-17 テルモ株式会社 生体適合性材料の評価方法
RU2616866C1 (ru) * 2015-12-31 2017-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Биорезорбируемый микроноситель для доставки клеток в область заживления и регенерации ран
RU2644633C1 (ru) * 2016-12-28 2018-02-13 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ восстановления кожного покрова
RU2658707C1 (ru) * 2016-12-28 2018-06-22 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ восстановления кожного покрова
CN110960513A (zh) * 2019-11-29 2020-04-07 苏州瑞微生物科技有限公司 一种微球阵列及其制备方法和用途
CN113201481B (zh) * 2021-04-19 2023-10-13 清华大学深圳国际研究生院 皮肤微球及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461002A1 (fr) * 1979-07-13 1981-01-30 Inst Nat Sante Rech Med Procede pour stimuler la croissance des cellules d'epiderme humain et produits faisant application dudit procede
CA1215922A (en) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation of living tissue and cells
EP0215274B1 (en) * 1985-08-14 1993-03-31 Memorial Hospital for Cancer and Allied Diseases Epidermal cell extracts and method to enhance wound healing and regenerate epidermis
FR2597499A1 (fr) * 1986-04-18 1987-10-23 Merieux Inst Procede de culture microbiologique sur supports de collagene, supports pour ce procede et produits obtenus
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US5015584A (en) * 1987-10-14 1991-05-14 Board Of Regents, The University Of Texas System Epidermal graft system
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
CA1307225C (en) * 1988-07-19 1992-09-08 David W. Armstrong Cell culture bioreactor
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
WO1990012604A1 (en) * 1989-04-25 1990-11-01 Vacanti Joseph P Method for implanting large volumes of cells on polymeric matrices
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord

Also Published As

Publication number Publication date
EP0641223A1 (en) 1995-03-08
KR100381207B1 (enExample) 2003-10-23
JP2820796B2 (ja) 1998-11-05
PT641223E (pt) 2001-12-28
DE69330562T2 (de) 2002-05-29
NZ252661A (en) 1996-09-25
US5830507A (en) 1998-11-03
CA2135999C (en) 1999-07-13
CA2135999A1 (en) 1993-11-25
RU2104039C1 (ru) 1998-02-10
WO1993023088A1 (en) 1993-11-25
ATE203916T1 (de) 2001-08-15
JPH07507063A (ja) 1995-08-03
KR950701533A (ko) 1995-04-28
EP0641223B1 (en) 2001-08-08
ES2161229T3 (es) 2001-12-01
RU94046192A (ru) 1996-10-10
GR3036741T3 (en) 2001-12-31
DK0641223T3 (da) 2001-10-01
DE69330562D1 (de) 2001-09-13
BR9306375A (pt) 1997-03-04
AU4257993A (en) 1993-12-13
AU668959B2 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
GB9210574D0 (en) Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
ATE125158T1 (de) Biologisch abbaubare und biologisch absorbierbare führungskanäle zur verwendung in der behandlung und regenerierung von nerven.
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
ZA943514B (en) The use of dihydrolipoic acid as an ophthalmological agent and to suppress intolerance reactions in the area between implants and living body tissue
WO1994007432A3 (en) Porous vascular implants
AR244354A1 (es) Membranas perforadas biocompatibles, procedimientos para su preparacion y piel artificial obtenida a partir de las mismas.
CA2197258A1 (en) Surgical suture
DE69231796D1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
EP0405556A3 (en) Living hard tissue replacement, its preparation, and preparation of integral body
CA2213533A1 (en) Resorbable extracellular matrix for reconstruction of cartilage tissue
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
CA2180659A1 (en) Use of a collagen membrane in preparation of an implant for guided tissue regeneration
DE69943067D1 (de) Verwendung von dreidimensionalen Prothesen, die Hyaluronsäurederivate enthalten
AU6002894A (en) Semi-synthetic material for medical and surgical use
CA2014542A1 (en) Medical implant and method for the manufacture thereof
ES2041977T3 (es) Impplante percutaneo.
EP0366029A3 (en) Bone repairing material and artificial bone fixing agent
GB9106174D0 (en) Staple applicator for use in the surgical treatment of female stress incontinence
Sevor et al. Placement of implants into fresh extraction sites using a resorbable collagen membrane
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
BR9606075C1 (pt) Composição injetável para uso médico.
CA2140888A1 (en) Biodegradable guide channels for use in tissue repair as surgical aids
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
Pratt Evisceration techniques
JPS6434359A (en) Novel high performance medical patch